Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1988 3
1989 4
1990 4
1991 2
1992 1
1993 2
1994 3
1996 1
2000 1
2002 3
2003 3
2004 12
2006 2
2007 8
2008 5
2009 7
2010 6
2011 3
2012 1
2013 3
2021 0
Text availability
Article attribute
Article type
Publication date

Similar articles for PMID: 18695181

71 results
Results by year
Filters applied: . Clear all
Page 1
Recombinant human Epo treatment: beneficial in chronic kidney disease, chronic heart failure, or both? Editorial to: "Correction of anemia with erythropoietin in chronic kidney disease (stage 3 or 4): effects on cardiac performance by Pappas et al.".
Belonje AM, de Boer RA, Voors AA. Belonje AM, et al. Cardiovasc Drugs Ther. 2008 Feb;22(1):1-2. doi: 10.1007/s10557-008-6079-x. Cardiovasc Drugs Ther. 2008. PMID: 18219567 Free PMC article. No abstract available.
Erythropoietin: high profile, high scrutiny.
Crawford J. Crawford J. J Clin Oncol. 2007 Mar 20;25(9):1021-3. doi: 10.1200/JCO.2006.08.8153. Epub 2007 Feb 20. J Clin Oncol. 2007. PMID: 17312331 No abstract available.
Amgen's point of view on epoetins.
Seidenberg B, Perlmutter RM. Seidenberg B, et al. Lancet Oncol. 2004 Apr;5(4):206-7. doi: 10.1016/S1470-2045(04)01422-6. Lancet Oncol. 2004. PMID: 15050950 No abstract available.
71 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page